Genpact's second quarter was defined by a single line of its income statement. The shares sit near $38, with a $6.4 billion market cap. The stock is inside a fifty-two week range of $26.85 to $48.64. That price level puts the multiple at a modest premium to the company's recent trading zone but still below where the stock traded a year ago. Its Advanced Technology Solutions business grew 24.1% in the quarter. That bucket contributed roughly 27 cents of every 100 the company billed, which is the single most important number in the entire filing. The core outsourcing business grew at a single digit, a pace closer to a mature utility than a services company, and the gap between those two growth rates is the entire investment story. Management called the combination a flywheel in motion and lifted full-year guidance for the technology arm to at least 25% growth in the same week its chief financial officer cited record bookings and a growing backlog. The balance sheet is now absorbing the cost of proving the pivot can compound through the year, and the two halves of the company are moving in opposite directions on the growth dial as a result.
Revenue rose 7.1% above the year-ago quarter, and constant currency growth was 6.9%. Gross margin expanded to 36.5% from 35.9% in the quarter. Adjusted operating margin edged to 17.4% from 17.3% as well, so the quarter combined genuine top-line acceleration with another stretch of year-over-year margin expansion. Adjusted diluted earnings per share of $1.00 rose 13.6%, faster than revenue, which is the arithmetic signature of mix shift working as management describes it. The market is paying for the technology re-acceleration but only partially, which leaves the valuation story open to revision in either direction as the September and December quarters print. That partial-credit stance is the cleanest framing of where the next twelve months sit, since the September print is likely to settle one way or the other whether the transformation narrative is fully embraced.
The counterweight is cash, and it is where the quarter's gloss thins out. Cash and equivalents fell by $336.4 million in the half, ending at $517.4 million. The company retired its 2021 senior notes, funded the XponentL earn-out, and accelerated buybacks at an average price of $35.57. First-half operating cash flow of $48.9 million against net income of $293.7 million is the figure skeptics point to, and it is largely a receivables and tax-payment timing story rather than an earnings-quality red flag. The forward variable that matters most is whether the technology arm holds its 25% growth pace through the second half while Core Business Services stops shrinking on a constant currency basis. The answer to that single question is likely to determine whether the stock reclaims the upper end of its range or settles into the middle, and that is why the September print is the most important setup for the name in some time.